Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis

Yang, Li; Huang, Jianhua; Ren, Xiubao; Gorska, Agnieszka E.; Chytil, Anna; Aakre, Mary; Carbone, David P.; Matrisian, Lynn M.; Richmond, Ann; Lin, P. Charles; Moses, Harold L.

doi:10.1016/j.ccr.2007.12.004

Cited by 925TGF-β signaling in diseasesImmune cells in cancerChemokine receptors and signaling

Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis

Open access

Yang, Li, Huang, Jianhua, Ren, Xiubao, Gorska, Agnieszka E., Chytil, Anna, Aakre, Mary, Carbone, David P., Matrisian, Lynn M. +3 more·2008·Cancer Cell

DOI 10.1016/j.ccr.2007.12.004PMC PMC2245859

Open this paper in CoChat — free account Open PDF

Abstract

Aberrant TGFbeta signaling is common in human cancers and contributes to tumor metastasis. Here, we demonstrate that Gr-1+CD11b+ myeloid cells are recruited into mammary carcinomas with type II TGF beta receptor gene (Tgfbr2) deletion and directly promote tumor metastasis. Gr-1+CD11b+ cells infiltrate into the invasive front of tumor tissues and facilitate tumor cell invasion and metastasis through a process involving metalloproteinase activity. This infiltration of Gr-1+CD11b+ cells also results in increased abundance of TGF beta 1 in tumors with Tgfbr2 deletion. The recruitment of Gr-1+CD11b+ cells into tumors with Tgfbr2 deletion involves two chemokine receptor axes, the SDF-1/CXCR4 and CXCL5/CXCR2 axes. Together, these data indicate that Gr-1+CD11b+ cells contribute to TGFbeta-mediated metastasis through enhancing tumor cell invasion and metastasis.

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2007.12.004

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Data from various mouse models indicate that disrupting the CXCR1/2-MDSC axis is therapeutically efficacious across a wide variety of solid cancers.
“Notably, data from various mouse models indicate that disrupting the CXCR1/2–MDSC axis in tumours is therapeutically efficacious across a wide variety of solid cancers166–172.”
From The current state of the art and future trends in RAS-targeted cancer therapies (2022) · cites this paper as [172]
TGF-β suppresses antigen presentation by DCs, impairing T-cell-mediated anti-tumor responses, and may suppress DC migration.
“TGF-β suppresses antigen presentation by DCs, thus impairing T-cell-mediated anti-tumor responses183, and may suppress DC cell migration184,185.”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [183]
TGF-β signaling suppresses processes that lead to CD8+ T cell activation and maturation, including, in APCs, expression of components of the antigen processing and presentation machinery, such as HLA/MHC.
“TGF-β signaling suppresses processes that lead to CD8+ T cell activation and maturation, including, in APCs, expression of components of the antigen processing and presentation machinery, such as HLA/MHC175,183,202.”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [183]

Inflammation and cancer
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111 · see citing works
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J. S., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,693 · see citing works
Endothelial Progenitor Cells
Urbich, C., & Dimmeler, S. (2004) · Circulation Research · doi:10.1161/01.res.0000137877.89448.78 · Cited by 2,364 · see citing works
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977 · see citing works
Self-citation
Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4
Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur, H., Many, A., Shultz, L., et al. (1999) · Science · doi:10.1126/science.283.5403.845 · Cited by 1,644 · see citing works
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,555 · see citing works
Self-citation
Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,340 · see citing works
Self-citation
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E. T., Sunshine, M. J., Littman, D. R., Kuo, C. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052144 · Cited by 1,264 · see citing works
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
Burger, J. A., & Kipps, T. J. (2005) · Blood · doi:10.1182/blood-2005-08-3182 · Cited by 1,172 · see citing works
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis
Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., & Lin, P. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.031 · Cited by 1,140 · see citing works
Self-citation
The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes
Balabanian, K., Lagane, B., Infantino, S., Chow, K. Y. C., Harriague, J., Moepps, B., Arenzana‐Seisdedos, F., Thelen, M., & Bachelerie, F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508234200 · Cited by 1,040 · see citing works
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Shojaei, F., Wu, X., Malik, A. K., Zhong, C., Baldwin, M. E., Schanz, S., Fuh, G., Gerber, H.-P., & Ferrara, N. (2007) · Nature Biotechnology · doi:10.1038/nbt1323 · Cited by 849 · see citing works
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment
Budhu, A., Forgues, M., Ye, Q.-H., Jia, H.-L., He, P., Zanetti, K. A., Kammula, U. S., Chen, Y., Qin, L., Tang, Z., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.016 · Cited by 843 · see citing works
Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression
Serafini, P., Borrello, I., & Bronte, V. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.005 · Cited by 758 · see citing works
TGF- β signaling in cancer – a double-edged sword
Akhurst, R. J., & Derynck, R. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02130-4 · Cited by 756 · see citing works
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF- B and enhanced IRF-3/STAT1 activation)
Biswas, S. K. (2005) · Blood · doi:10.1182/blood-2005-01-0428 · Cited by 693 · see citing works
Membrane Type I Matrix Metalloproteinase Usurps Tumor Growth Control Imposed by the Three-Dimensional Extracellular Matrix
Hotary, K. B., Allen, E. D., Brooks, P. C., Datta, N. S., Long, M. W., & Weiss, S. J. (2003) · Cell · doi:10.1016/s0092-8674(03)00513-0 · Cited by 677 · see citing works
The Chemokine Receptor CXCR-4 Is Expressed on CD34+Hematopoietic Progenitors and Leukemic Cells and Mediates Transendothelial Migration Induced by Stromal Cell-Derived Factor-1
Möhle, R., Bautz, F., Rafii, S., Moore, M. A. S., Brugger, W., & Kanz, L. (1998) · Blood · doi:10.1182/blood.v91.12.4523 · Cited by 648 · see citing works
Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes
Jin, D. K., Shido, K., Kopp, H., Petit, I., Shmelkov, S. V., Young, L. M., Hooper, A. T., Amano, H., Avecilla, S. T., Heissig, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1400 · Cited by 645 · see citing works
An inflammatory link
Balkwill, F. R., & Coussens, L. M. (2004) · Nature · doi:10.1038/431405a · Cited by 627 · see citing works
Identification of a CD11b+/Gr-1+/CD31+ myeloid progenitor capable of activating or suppressing CD8+T cells
Bronte, V., Apolloni, E., Cabrelle, A., Ronca, R., Serafini, P., Zamboni, P., Restifo, N. P., & Zanovello, P. (2000) · Blood · doi:10.1182/blood.v96.12.3838 · Cited by 527 · see citing works
High-Dose Granulocyte-Macrophage Colony-Stimulating Factor-Producing Vaccines Impair the Immune Response through the Recruitment of Myeloid Suppressor Cells
Serafini, P., Carbley, R., Noonan, K. A., Tan, G. G. Y., Bronte, V., & Borrello, I. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0757 · Cited by 524 · see citing works
TGF-β and cancer
Bierie, B., & Moses, H. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.006 · Cited by 476 · see citing works
Self-citation
Membrane‐Type Matrix Metalloproteinases 1 and 2 Exhibit Broad‐Spectrum Proteolytic Capacities Comparable to Many Matrix Metalloproteinases
d’Ortho, M., Will, H., Atkinson, S. J., Butler, G. S., Messent, A., Gavrilović, J., Smith, B., Timpl, R., Zardi, L., & Murphy, G. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00751.x · Cited by 443 · see citing works
Transforming growth factor β signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis
Siegel, P. M., Shu, W., Cardiff, R. D., Muller, W. J., & Massagué, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932636100 · Cited by 429 · see citing works
The CXC Chemokines Growth-regulated Oncogene (GRO) α, GROβ, GROγ, Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 Receptor
Ahuja, S. K., & Murphy, P. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20545 · Cited by 425 · see citing works
Matrix metalloproteinases in tumor–host cell communication
Lynch, C. C., & Matrisian, L. M. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700909.x · Cited by 384 · see citing works
Self-citation
Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-β signaling in cooperation with active Kras expression
Ijichi, H., Chytil, A., Gorska, A. E., Aakre, M. E., Fujitani, Y., Fujitani, S., Wright, C. V. E., & Moses, H. L. (2006) · Genes & Development · doi:10.1101/gad.1475506 · Cited by 379 · see citing works
Self-citation
GENETIC AND EPIGENETIC ALTERATIONS IN COLON CANCER
Grady, W. M., & Markowitz, S. D. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.022502.103043 · Cited by 318 · see citing works
Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency
Tang, B., Böttinger, E. P., Jakowlew, S. B., Bagnall, K. M., Mariano, J. M., Anver, M. R., Letterio, J. J., & Wakefield, L. M. (1998) · Nature Medicine · doi:10.1038/nm0798-802 · Cited by 315 · see citing works
Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity
Melani, C. C., Chiodoni, C., Forni, G., & Colombo, M. P. (2003) · Blood · doi:10.1182/blood-2003-01-0190 · Cited by 295 · see citing works
SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion
Kitamura, T., Kometani, K., Hashida, H., Matsunaga, A., Miyoshi, H., Hosogi, H., Aoki, M., Oshima, M., Hattori, M., Takabayashi, A., et al. (2007) · Nature Genetics · doi:10.1038/ng1997 · Cited by 282 · see citing works
Conditional inactivation of the TGF‐β type II receptor using Cre:Lox
Chytil, A. M., Magnuson, M. A., Wright, C. V. E., & Moses, H. L. (2002) · genesis · doi:10.1002/gene.10046 · Cited by 269 · see citing works
Self-citation
Effect of Conditional Knockout of the Type II TGF-β Receptor Gene in Mammary Epithelia on Mammary Gland Development and Polyomavirus Middle T Antigen Induced Tumor Formation and Metastasis
Forrester, E., Chytil, A., Bierie, B., Aakre, M. E., Gorska, A. E., Sharif‐Afshar, A., Muller, W. J., & Moses, H. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3272 · Cited by 248 · see citing works
Self-citation
The Structure, Regulation, and Function of Human Matrix Metalloproteinase-13
Leeman, M. F., Curran, S., & Murray, G. I. (2002) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230290771483 · Cited by 215 · see citing works
Loss of transforming growth factor-β type II receptor promotes metastatic head-and-neck squamous cell carcinomaPreprint
Lu, S., Herrington, H. C., Reh, D. D., Weber, S. M., Bornstein, S., Wang, D., Li, A. G., Tang, C.-F., Siddiqui, Y., Nord, J., et al. (2006) · Genes & Development · doi:10.1101/gad.1413306 · Cited by 204 · see citing works
Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice.
Engle, S. J., Ormsby, I., Pawlowski, S. A., Boivin, G. P., Croft, J., Balish, E., & Doetschman, T. C. (2002) · PubMed · Cited by 199 · see citing works
Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor β1
Muraoka, R. S., Koh, Y., Roebuck, L. R., Sanders, M. E., Brantley‐Sieders, D. M., Gorska, A. E., Moses, H. L., & Arteaga, C. L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8691-8703.2003 · Cited by 191 · see citing works
Self-citation
Neutrophils and respiratory tract DNA damage and mutagenesis: a review
Knaapen, A. M. (2006) · Mutagenesis · doi:10.1093/mutage/gel032 · Cited by 184 · see citing works
Transforming Growth Factor β Receptor Type II Inactivation Induces the Malignant Transformation of Intestinal Neoplasms Initiated by Apc Mutation
Muñoz, N. M., Upton, M. P., Muñoz-Rojas, A. R., Washington, M. K., Li, L., Chytil, A. M., Sözmen, E. G., Madison, B., Pozzi, A., Moon, R. T., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0890 · Cited by 168 · see citing works
Self-citation
Conditional Overexpression of Active Transforming Growth Factor β1 In vivo Accelerates Metastases of Transgenic Mammary Tumors
Muraoka-Cook, R. S., Kurokawa, H., Koh, Y., Forbes, J. T., Roebuck, L. R., Barcellos‐Hoff, M. H., Moody, S. E., Chodosh, L. A., & Arteaga, C. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2111 · Cited by 159 · see citing works
Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumours
Jamieson, S., Going, J. J., D'Arcy, R., & George, W. D. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199801)184:1 · Cited by 157 · see citing works
Induction of CXCL5 During Inflammation in the Rodent Lung Involves Activation of Alveolar Epithelium
Jeyaseelan, S., Manzer, R., Young, S. K., Yamamoto, M., Akira, S., Mason, R. J., & Worthen, G. S. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0063oc · Cited by 154 · see citing works
Transforming Growth Factor β Receptor Type II Inactivation Promotes the Establishment and Progression of Colon Cancer
Biswas, S., Chytil, A. M., Washington, K., Romero–Gallo, J., Gorska, A. E., Wirth, P. S., Gautam, S., Moses, H. L., & Grady, W. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3255 · Cited by 153 · see citing works
Self-citation
Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer.
Chen, T., Carter, D., Garrigue‐Antar, L., & Reiss, M. (1998) · PubMed · Cited by 150 · see citing works
Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis
Wente, M. N., Keane, M. P., Burdick, M. D., Frieß, H., Büchler, M. W., Ceyhan, G. O., Reber, H. A., Strieter, R. M., & Hines, O. J. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.10.041 · Cited by 141 · see citing works
Activated type I TGFβ receptor kinase enhances the survival of mammary epithelial cells and accelerates tumor progression
Muraoka-Cook, R. S., Shin, I., Yi, J. Y., Easterly, E., Barcellos‐Hoff, M. H., Yingling, J. M., Zent, R., & Arteaga, C. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208964 · Cited by 137 · see citing works
Transforming Growth Factor-β and Breast Cancer Risk in Women With Mammary Epithelial Hyperplasia
Gobbi, H., Dupont, W. D., Simpson, J. F., Plummer, W. D., Schuyler, P. A., Olson, S. J., Arteaga, C. L., & Page, D. L. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.24.2096 · Cited by 130 · see citing works
Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions
HOCHREITER, W. W., Nadler, R. B., Koch, A. E., Campbell, P. L., Ludwig, M., Weidner, W., & Schaeffer, A. J. (2000) · Urology · doi:10.1016/s0090-4295(00)00844-x · Cited by 127 · see citing works
Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers
Young, M. R., & Lathers, D. M. R. (1999) · International Journal of Immunopharmacology · doi:10.1016/s0192-0561(99)00008-9 · Cited by 96 · see citing works
Somatic Acquisition and Signaling of TGFBR1 *6A in Cancer
Pasche, B. (2005) · JAMA · doi:10.1001/jama.294.13.1634 · Cited by 93 · see citing works
Characterization of the Role of the “MT-loop”
English, W., Holtz, B., Vogt, G., Knäuper, V., & Murphy, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107783200 · Cited by 82 · see citing works
Nonpeptide CXCR2 Antagonist Prevents Neutrophil Accumulation in Hyperoxia-Exposed Newborn Rats
Auten, R. L., Richardson, R. M., White, J. R., Mason, S. N., Vozzelli, M. A., & Whorton, M. H. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29305-8 · Cited by 78 · see citing works
Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin
Jessen, K. A., Liu, S. Y., Tepper, C. G., Karrim, J., McGoldrick, E. T., Rosner, A., Munn, R. J., Young, L. J. T., Borowsky, A. D., Cardiff, R. D., et al. (2004) · Breast Cancer Research · doi:10.1186/bcr768 · Cited by 52 · see citing works
Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer
Bagadi, S. A. R., Prasad, C. P., Srivastava, A., Prashad, R., Gupta, S. D., & Ralhan, R. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9422-6 · Cited by 48 · see citing works
Int7G24A Variant of Transforming Growth Factor-β Receptor Type I Is Associated with Invasive Breast Cancer
Chen, T., Jackson, C. R., Link, A. J., Markey, M. P., Colligan, B. M., Douglass, L. E., Pemberton, J. O., Deddens, J. A., Graff, J. R., & Carter, J. H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1518 · Cited by 47 · see citing works
Identification of microsatellite instability and mismatch repair gene mutations in breast cancer cell lines
Seitz, S., Waβmuth, P., Plaschke, J., Schackert, H. K., Karsten, U., Santibanez‐Koref, M., Schlag, P. M., & Scherneck, S. (2003) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10196 · Cited by 35 · see citing works
Cell dissociation techniques in human breast cancer — Variations in tumor cell viability and DNA ploidy
Ljung, B., Mayall, B. H., Lottich, C., Boyer, C. M., Sylvester, S. S., Leight, G. S., Siegler, H. F., & Smith, H. S. (1989) · Breast Cancer Research and Treatment · doi:10.1007/bf01806527 · Cited by 32 · see citing works
Receptor Binding Specificity and Pulmonary Gene Expression of the Neutrophil-Activating Peptide ENA-78
Bozic, C. R., Gerard, N. P., & Gerard, C. J. (1996) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.14.3.8845182 · Cited by 30 · see citing works
CXCL5 gene polymorphisms are related to systemic concentrations and leukocyte production of epithelial neutrophil-activating peptide (ENA-78)
Zineh, I., Aquilante, C. L., Langaee, T. Y., Beitelshees, A. L., Arant, C. B., Wessel, T. R., & Schofield, R. S. (2006) · Cytokine · doi:10.1016/j.cyto.2006.02.008 · Cited by 22 · see citing works

Flagged first, then by citations

1 of the 61 references couldn’t be matched to a known paper.

Sorted by citations

Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755 · see citing works
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · see citing works
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Sharma, P., Hu-Lieskovan, S., Wargo, J. A., & Ribas, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.017 · Cited by 5,588 · see citing works
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089 · see citing works
TGFβ in Cancer
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907 · see citing works
Inflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806 · see citing works
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684 · see citing works
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544 · see citing works
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,882 · see citing works
Transforming Growth Factor-β Signaling in Immunity and Cancer
Batlle, E., & Massagué, J. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.024 · Cited by 2,366 · see citing works
Imaging in the era of molecular oncology
Weissleder, R., & Pittet, M. J. (2008) · Nature · doi:10.1038/nature06917 · Cited by 2,372 · see citing works
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nagarsheth, N., Wicha, M. S., & Zou, W. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.49 · Cited by 2,217 · see citing works
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Kumar, V., Patel, S., Tcyganov, E., & Gabrilovich, D. I. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.01.004 · Cited by 2,008 · see citing works
Inflammation and Colon Cancer
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974 · see citing works
Neutrophils in cancer: Neutral no more
Coffelt, S. B., Wellenstein, M. D., & de Visser, K. E. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.52 · Cited by 1,830 · see citing works
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Ostrand‐Rosenberg, S., & Sinha, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802740 · Cited by 1,733 · see citing works
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642 · see citing works
Helicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk
Wroblewski, L. E., Peek, R. M., & Wilson, K. T. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00011-10 · Cited by 1,455 · see citing works
CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages
DeNardo, D. G., Barreto, J., Andreu, P., Vásquez, L. J., Tawfik, D., Kolhatkar, N. S., & Coussens, L. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.018 · Cited by 1,354 · see citing works
The metastatic niche: adapting the foreign soil
Psaila, B., & Lyden, D. C. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2621 · Cited by 1,302 · see citing works
Tumors as Organs: Complex Tissues that Interface with the Entire Organism
Egeblad, M., Nakasone, E. S., & Werb, Z. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.05.012 · Cited by 1,230 · see citing works
Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche
Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., Le, Q.-T., & Giaccia, A. J. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.11.012 · Cited by 1,231 · see citing works
Immune cell promotion of metastasis
Kitamura, T., Qian, B.-Z., & Pollard, J. W. (2015) · Nature Reviews Immunology · doi:10.1038/nri3789 · Cited by 1,158 · see citing works
History of myeloid-derived suppressor cells
Talmadge, J. E., & Gabrilovich, D. I. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3581 · Cited by 1,148 · see citing works
TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
Yang, L., Pang, Y., & Moses, H. L. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.04.002 · Cited by 1,023 · see citing works
Self-citation
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
McAllister, S. S., & Weinberg, R. A. (2014) · Nature Cell Biology · doi:10.1038/ncb3015 · Cited by 966 · see citing works
TGFβ biology in cancer progression and immunotherapy
Derynck, R., Turley, S. J., & Akhurst, R. J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0403-1 · Cited by 944 · see citing works
Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer
Bayne, L. J., Beatty, G. L., Jhala, N., Clark, C. E., Rhim, A. D., Stanger, B. Z., & Vonderheide, R. H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.025 · Cited by 947 · see citing works
“Other potential roles of Gr-1+ CD11b+ cells in regulating tumor growth (Yang et al., 2004, 2008, 2011) appear therefore to be secondary or noncontributory to tumor growth, at least in this assay.”
Background
The roles of TGFβ in the tumour microenvironment
Pickup, M. W., Novitskiy, S. V., & Moses, H. L. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3603 · Cited by 914 · see citing works
Self-citation
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
Steele, C. W., Karim, S. A., Leach, J. D. G., Bailey, P. J., Upstill‐Goddard, R., Rishi, L., Foth, M., Bryson, S., McDaid, K., Wilson, Z., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.014 · Cited by 850 · see citing works
Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
Condamine, T., & Gabrilovich, D. I. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.10.002 · Cited by 846 · see citing works
Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in Mice
Tu, S., Bhagat, G., Cui, G., Takaishi, S., Kurt‐Jones, E. A., Rickman, B. H., Betz, K. S., Penz-Österreicher, M., Björkdahl, O., Fox, J. G., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.011 · Cited by 815 · see citing works
Roles of TGFβ in metastasis
Padua, D. M., & Massagué, J. (2008) · Cell Research · doi:10.1038/cr.2008.316 · Cited by 810 · see citing works
Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
Highfill, S. L., Cui, Y., Giles, A. J., Smith, J. P., Zhang, H., Morse, E., Kaplan, R. N., & Mackall, C. L. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007974 · Cited by 767 · see citing works
“(33) showed that Gr1CD11b MDSCs are recruited into murine mammary carcinomas via a CXCR2-dependent mechanism and, once there, act to promote tumor invasion and metastasis.”
Background
NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer
Fan, Y., Mao, R., & Yang, J. (2013) · Protein & Cell · doi:10.1007/s13238-013-2084-3 · Cited by 779 · see citing works
Genetics and biology of prostate cancerPreprint
Wang, G., Zhao, D., Spring, D. J., & DePinho, R. A. (2018) · Genes & Development · doi:10.1101/gad.315739.118 · Cited by 758 · see citing works
Developmental and Pathological Angiogenesis
Chung, A. S., & Ferrara, N. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154002 · Cited by 722 · see citing works
LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer
Wang, Y., Zhang, H., Chen, Y., Sun, Y., Yang, F., Yu, W., Liang, J., Sun, L., Yang, X., Shi, L., et al. (2009) · Cell · doi:10.1016/j.cell.2009.05.050 · Cited by 699 · see citing works
Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression
Zamarron, B. F., & Chen, W. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.651 · Cited by 681 · see citing works
Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes
Kowanetz, M., Wu, X., Lee, J., Tan, M., Hagenbeek, T., Qu, X., Yu, L., Ross, J., Korsisaari, N., Cao, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015855107 · Cited by 663 · see citing works
Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?
Fares, C. M., Allen, E. M. V., Drake, C. G., Allison, J. P., & Hu‐Lieskovan, S. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_240837 · Cited by 648 · see citing works
Chemokines and chemokine receptors: new insights into cancer-related inflammation
Lazennec, G., & Richmond, A. J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.01.003 · Cited by 651 · see citing works
Self-citation
Inflaming metastasis
Mantovani, A. (2008) · Nature · doi:10.1038/457036b · Cited by 646 · see citing works
Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
Schaaf, M. B., Garg, A. D., & Agostinis, P. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0061-0 · Cited by 629 · see citing works
KRAS-IRF2 axis drives immune suppression and immune therapy resistance in colorectal cancer
Liao, W., Overman, M. J., Boutin, A. T., Shang, X., Zhao, D., Dey, P., Li, J., Wang, G., Lan, Z., Li, J., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.02.008 · Cited by 617 · see citing works
Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer
Yu, J., Du, W., Fang, Y., Wang, Y., Li, H., Cao, S., Yu, W., Shen, C., Liu, J., & Ren, X. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201449 · Cited by 608 · see citing works
Self-citation
Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin
Ginwala, R., Bhavsar, R., Chigbu, D. I., Jain, P., & Khan, Z. K. (2019) · Antioxidants · doi:10.3390/antiox8020035 · Cited by 613 · see citing works
Stat3 mediates myeloid cell–dependent tumor angiogenesis in mice
Kujawski, M., Kortylewski, M., Lee, H., Herrmann, A., Kay, H. D., & Yu, H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35213 · Cited by 581 · see citing works
The biology of myeloid‐derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity
Youn, J., & Gabrilovich, D. I. (2010) · European Journal of Immunology · doi:10.1002/eji.201040895 · Cited by 568 · see citing works
Platelets guide the formation of early metastatic niches
Labelle, M., Begum, S., & Hynes, R. O. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411082111 · Cited by 555 · see citing works
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
Wang, G., Lü, X., Dey, P., Deng, P., Wu, C.-C., Jiang, S., Fang, Z., Zhao, K., Konaparthi, R., Hua, S., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0224 · Cited by 556 · see citing works
Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity
Swartz, M. A., & Lund, A. W. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3186 · Cited by 544 · see citing works
The current state of the art and future trends in RAS-targeted cancer therapies
Punekar, S. R., Velcheti, V., Neel, B. G., & Wong, K.-K. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00671-9 · Cited by 549 · see citing works
Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
Erin, N., Grahovac, J., Brozovic, A., & Efferth, T. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100715 · Cited by 527 · see citing works
Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
Condamine, T., Ramachandran, I., Youn, J., & Gabrilovich, D. I. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-051013-052304 · Cited by 521 · see citing works
Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice
Youn, J., Collazo, M. M., Shalova, I. N., Biswas, S. K., & Gabrilovich, D. I. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0311177 · Cited by 510 · see citing works
Regulation of EMT by TGFβ in cancer
Heldin, C., Vanlandewijck, M., & Moustakas, A. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.02.037 · Cited by 502 · see citing works
Myeloid-derived suppressor cells in cancer and cancer therapy
Lasser, S., Kurt, F. G. Ö., Arkhypov, I., Utikal, J. S., & Umansky, V. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00846-y · Cited by 514 · see citing works
Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
Bidwell, B. N., Slaney, C. Y., Withana, N. P., Forster, S., Cao, Y., Loi, S., Andrews, D., Mikeska, T., Mangan, N. E., Samarajiwa, S. A., et al. (2012) · Nature Medicine · doi:10.1038/nm.2830 · Cited by 487 · see citing works
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
Zhang, X., Claerhout, S., Prat, A., Dobrolecki, L. E., Petrovic, I., Lai, Q., Landis, M. D., Wiechmann, L., Schiff, R., Giuliano, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4081 · Cited by 483 · see citing works
Self-citation
CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis
Katoh, H., Wang, D., Daikoku, T., Sun, H., Dey, S. K., & DuBois, R. N. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.009 · Cited by 477 · see citing works
Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model
Liao, D., Luo, Y., Markowitz, D., Xiang, R., & Reisfeld, R. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007965 · Cited by 437 · see citing works
Targeting TGFβ signal transduction for cancer therapy
Liu, S., Ren, J., & ten Dijke, P. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00436-9 · Cited by 413 · see citing works
Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin
McAllister, S. S., Gifford, A. M., Greiner, A. L., Kelleher, S. P., Saelzler, M. P., Ince, T. A., Reinhardt, F., Harris, L. N., Hylander, B. L., Repasky, E. A., et al. (2008) · Cell · doi:10.1016/j.cell.2008.04.045 · Cited by 431 · see citing works
Neutrophils in Cancer: Two Sides of the Same Coin
Uribe‐Querol, E., & Rosales, C. (2015) · Journal of Immunology Research · doi:10.1155/2015/983698 · Cited by 425 · see citing works
The pre-metastatic niche: finding common ground
Sceneay, J., Smyth, M. J., & Möller, A. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9420-1 · Cited by 422 · see citing works
The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment
Sionov, R. V., Fridlender, Z. G., & Granot, Z. (2014) · Cancer Microenvironment · doi:10.1007/s12307-014-0147-5 · Cited by 415 · see citing works
Macrophages define the invasive microenvironment in breast cancer
Pollard, J. W. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107762 · Cited by 414 · see citing works
Pancreatic Cancer-Associated Stellate Cells Promote Differentiation of Myeloid-Derived Suppressor Cells in a STAT3-Dependent Manner
Mace, T. A., Ameen, Z., Collins, A., Wojcik, S. E., Mair, M., Young, G. S., Fuchs, J. R., Eubank, T. D., Frankel, W. L., Bekaii‐Saab, T., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4601 · Cited by 413 · see citing works
Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer
Chen, I. X., Chauhan, V. P., Posada, J., Ng, M. R., Wu, M. W., Adstamongkonkul, P., Huang, P., Lindeman, N., Langer, R., & Jain, R. K. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815515116 · Cited by 406 · see citing works
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Lin, H., Liu, C., Hu, A.-K., Zhang, D., Yang, H., & Mao, Y. Q. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01544-7 · Cited by 421 · see citing works
Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis
Jamieson, T., Clarke, M., Steele, C. W., Samuel, M. S., Neumann, J., Jung, A., Huels, D., Olson, M. F., Das, S., Nibbs, R. J. B., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61067 · Cited by 391 · see citing works
The chemokine system in cancer biology and therapy
Mantovani, A., Savino, B., Locati, M., Zammataro, L. A., Allavena, P., & Bonecchi, R. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.007 · Cited by 395 · see citing works
Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
Li, X., Shao, C., Shi, Y., & Han, W. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0578-4 · Cited by 385 · see citing works
Migratory neighbors and distant invaders: tumor-associated niche cellsPreprint
Wels, J., Kaplan, R. N., Rafii, S., & Lyden, D. C. (2008) · Genes & Development · doi:10.1101/gad.1636908 · Cited by 381 · see citing works
Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy
Vilgelm, A. E., & Richmond, A. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00333 · Cited by 372 · see citing works
Self-citation
Gr-1+CD11b+ Myeloid Cells Tip the Balance of Immune Protection to Tumor Promotion in the Premetastatic Lung
Yan, H. H., Pickup, M. W., Pang, Y., Gorska, A. E., Li, Z., Chytil, A. M., Geng, Y., Gray, J. W., Moses, H. L., & Yang, L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0706 · Cited by 372 · see citing works
Self-citation
Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor
Toh, B., Wang, X., Keeble, J., Sim, W. J., Khoo, K., Wong, W. C., Kato, M., Prévost‐Blondel, A., Thiery, J. P., & Abastado, J. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001162 · Cited by 369 · see citing works
Chemokines in health and disease
Raman, D., Sobolik-Delmaire, T., & Richmond, A. J. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.01.005 · Cited by 366 · see citing works
Self-citation
CCR2-Dependent Recruitment of Macrophages by Tumor-Educated Mesenchymal Stromal Cells Promotes Tumor Development and Is Mimicked by TNFα
Ren, G., Zhao, X., Wang, Y., Zhang, X., Chen, X., Xu, C., Yuan, Z.-R., Roberts, A. I., Zhang, L., Zheng, H. B., et al. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.08.013 · Cited by 363 · see citing works
Molecular networks that regulate cancer metastasis
Spano, D., Heck, C., Antonellis, P. D., Christofori, G., & Zollo, M. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.03.006 · Cited by 360 · see citing works
Tumor-induced perturbations of cytokines and immune cell networks
Burkholder, B., Huang, R.-Y., Burgess, R., Luo, S., Jones, V. S., Zhang, W., Lv, Z., Gao, C., Wang, B.-L., Zhang, Y., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.01.004 · Cited by 354 · see citing works
Immunosuppression associated with chronic inflammation in the tumor microenvironment
Wang, D., & DuBois, R. N. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv123 · Cited by 358 · see citing works
Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade
Holmgaard, R. B., Schaer, D. A., Li, Y., Castaneda, S. P., Murphy, M. Y., Xu, X., Inigo, I., Dobkin, J., Manro, J. R., Iversen, P. W., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0356-4 · Cited by 356 · see citing works
Strategies for the discovery and development of therapies for metastatic breast cancer
Eckhardt, B. L., Francis, P. A., Parker, B. S., & Anderson, R. L. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd2372 · Cited by 352 · see citing works
Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation
Mantovani, A., Sica, A., Allavena, P., Garlanda, C., & Locati, M. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.02.008 · Cited by 350 · see citing works
Chemokines in tumor progression and metastasis
Sarvaiya, P. J., Guo, D., Ulasov, I. V., Gabikian, P., & Lesniak, M. S. (2013) · Oncotarget · doi:10.18632/oncotarget.1426 · Cited by 349 · see citing works
Complexities of TGF-β Targeted Cancer Therapy
Connolly, E. C., Freimuth, J., & Akhurst, R. J. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4564 · Cited by 344 · see citing works
Neutrophil phenotypes and functions in cancer: A consensus statement
Quail, D. F., Amulic, B., Aziz, M., Barnes, B. J., Eruslanov, E. B., Fridlender, Z. G., Goodridge, H. S., Granot, Z., Hidalgo, A., Anna Huttenlocher, A., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220011 · Cited by 336 · see citing works
Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells
Zhou, J., Nefedova, Y., Lei, A., & Gabrilovich, D. I. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.12.004 · Cited by 343 · see citing works
Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function
Sander, L. E., Sackett, S. D., Dierssen, U., Beraza, N., LINKE, R. P., Müller, M. M., Blander, J. M., Tacke, F., & Trautwein, C. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091474 · Cited by 337 · see citing works
Chapter 8 The Role of NKT Cells in Tumor Immunity
Terabe, M., & Berzofsky, J. A. (2008) · Advances in cancer research · doi:10.1016/s0065-230x(08)00408-9 · Cited by 333 · see citing works
Transforming growth factor beta (TGF-β) and inflammation in cancer
Bierie, B., & Moses, H. L. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.008 · Cited by 331 · see citing works
Self-citation
Cytokines as a key component of cancer-related inflammation
Germano, G., Allavena, P., & Mantovani, A. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.014 · Cited by 331 · see citing works
The reactive stroma microenvironment and prostate cancer progression
Barron, D. A., & Rowley, D. R. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0085 · Cited by 331 · see citing works
Tumor-Host Interactions: A Far-Reaching Relationship
McAllister, S. S., & Weinberg, R. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.4257 · Cited by 326 · see citing works
Inflammation: A driving force speeds cancer metastasis
Wu, Y., & Zhou, B. P. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9699 · Cited by 327 · see citing works
Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis
Waight, J. D., Netherby, C. S., Hensen, M. L., Miller, A., Hu, Q., Liu, S., Bogner, P. N., Farren, M. R., Lee, K. P., Liu, K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68189 · Cited by 324 · see citing works
Immune microenvironments in solid tumors: new targets for therapyPreprint
Shiao, S. L., Ganesan, A.-P., Rugo, H. S., & Coussens, L. M. (2011) · Genes & Development · doi:10.1101/gad.169029.111 · Cited by 320 · see citing works
Mechanisms of the Epithelial–Mesenchymal Transition by TGF-β
Wendt, M. K., Allington, T. M., & Schiemann, W. P. (2009) · Future Oncology · doi:10.2217/fon.09.90 · Cited by 318 · see citing works

614 Mechanisms of cell signalling in metastasis
Marshall, C. (2010) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(10)71415-4
TGFβ betrays immunity for tumorigenesis
Minton, K. (2008) · Nature reviews. Immunology · doi:10.1038/nri2263 · Cited by 1 · see citing works
TGFβ Signaling in Myeloid Cells Regulates Mammary Carcinoma Cell Invasion through Fibroblast Interactions
Shaw, A. K., Pickup, M. W., Chytil, A. M., Aakre, M. E., Owens, P., Moses, H. L., & Novitskiy, S. V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117908 · Cited by 17 · see citing works
Self-citation
RESEARCH ARTICLE TGFβ Signaling in Myeloid Cells Regulates Mammary Carcinoma Cell Invasion through Fibroblast Interactions
Shaw, A. K., Pickup, M. W., Chytil, A. M., Aakre, M. E., Owens, P., Moses, L., & Novitskiy, S. V. (2016)
Self-citation
Abstract 5320: Deletion of TGFß signaling in Gr-1+CD11b+ myeloid cells attenuates breast adenocarcinoma progression
Pang, Y., Yan, H. H., Li, C., Achyut, B. R., & Yang, L. (2010) · Cancer Research · doi:10.1158/1538-7445.am10-5320
Self-citation

Authors: Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P., Matrisian, L. M., Richmond, A., Lin, P. C., & Moses, H. L.
Affiliations: Vanderbilt University (US)
Corresponding author: Moses, Harold L.
ORCID: Huang, Jianhua
Ren, Xiubao
Gorska, Agnieszka E.
Carbone, David P.
Matrisian, Lynn M.
Richmond, Ann
Moses, Harold L.
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2008-01
Volume: 13
Issue: 1
Pages: 23-35
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/j.ccr.2007.12.004
PMC: PMC2245859
OpenAlex: W2130870648
Cited by: 918
References: 61
Citations by year: 2026: 10 · 2025: 19 · 2024: 30 · 2023: 25 · 2022: 41 · 2021: 58 · 2020: 41 · 2019: 52 · 2018: 42 · 2017: 47 · 2016: 62 · 2015: 59 · 2014: 64 · 2013: 78 · 2012: 77
FWCI: 29.18
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 2024 d)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: U.S. Department of Veterans Affairs (IK6 BX005225)
Vanderbilt University
National Cancer Institute (CA068485, CA 085492, R01CA085492, R01CA116021, CA102162, R01CA108856, CA126505, R01CA076321, R01CA034590, P50CA098131, R01CA102162, CA108856, P30CA068485, U54CA126505)
National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK58404, P30DK058404)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
Keywords: TGF-beta signaling, breast cancer, tumor-associated macrophages, metastasis, tumor invasion, metalloproteinase activity, SDF-1/CXCR4 axis, chemokine receptors, myeloid cell recruitment
MeSH terms: Receptor, Transforming Growth Factor-beta Type II, Animals, Breast Neoplasms, Female, Humans, Models, Biological, Neoplasm Invasiveness, Neoplasm Metastasis, Signal Transduction, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Gene Deletion, Receptors, Transforming Growth Factor beta, Matrix Metalloproteinases, Myeloid Cells, CD11b Antigen, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks